QUIDEL QUICKVUE® DIPSTICK STREP A TEST

The QuickVue Dipstick Strep A test allows for the rapid qualitative detection of Group A Streptococcal antigen directly from patient throat swab specimens, or confirmation of presumptive Group A Streptococcal colonies recovered from culture. The test is intended for use as an aid in the diagnosis of Group A Streptococcal infection.

The QuickVue Dipstick Strep A test is a lateral flow immunoassay utilizing Quidel's patented antibody-labeled particles (within 5 minutes). The test detects either viable or nonviable organisms directly from throat swabs or culture colonies.

To perform the test, a throat swab specimen is collected. Antigen is extracted from the swab specimen with Reagents A and B. The Dipstick is then added to the extracted sample.

• 5 minutes to result: Patient can be tested and treated in the same office visit. Increases office efficiency and reduces patient follow-up activities.
• Two-color endpoint: Easy to read and interpret results. Decreased risk of misinterpretation.
• Two-reagent procedure: Fewer procedural steps, decreasing the risk of operator error.
• Pictorial procedure guide: Simplifies understanding of testing procedure, which increases reliability.
• Room temperature storage: No need to warm-up reagents. Does not take up valuable refrigerator space. Tests can be run when needed.
• 18 month shelf life: Less chance of product expiring before use.
• Built-in internal controls: Ensures system functionality, which increases confidence in results.
• Self contained kit design: All components needed to perform 50 tests are contained in the kit including the swabs.